Novel CD73 Inhibitors for Treating Cancer.
Rachel MataPublished in: ACS medicinal chemistry letters (2024)
Provided herein are novel CD73 inhibitors, pharmaceutical compositions, use of such compounds in treating cancer, and processes for preparing such compounds.